DIANA HUNTER-ELDRIDGE: Open Payments
NPI 1346948478 · GROVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 48 payments from 10 companies in 2025. Trend: 2023 $349 · 2024 $514 · 2025 $1,830
Food & beverage: $1,830
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $342 |
| Axsome Therapeutics, Inc. | 7 | $322 |
| Neuronetics, Inc. | 3 | $317 |
| Otsuka America Pharmaceutical, Inc. | 11 | $188 |
| Teva Pharmaceuticals USA, Inc. | 4 | $180 |
| TMS NeuroHealth Centers Inc. | 1 | $139 |
| ABBVIE INC. | 8 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: COBENFY, Auvelity, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, UZEDY, TMS NeuroHealth Centers Inc., VRAYLAR, INGREZZA.
Industry payments across NC — which companies pay providers there.
